Declan Doogan
CIK: 0001704234
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TENAX THERAPEUTICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 16, 2026TENX
TENAX THERAPEUTICS, INC.
Purchase(P)Direct53K shares at avg. $1.92$102K - Jan 9, 2026TENX
TENAX THERAPEUTICS, INC.
Award(A)DirectStock Option (right to buy)
30K shares- - Jul 1, 2025TENX
TENAX THERAPEUTICS, INC.
Award(A)DirectStock Option (right to buy)
80K shares- - Dec 10, 2024TENX
TENAX THERAPEUTICS, INC.
Award(A)DirectStock Option (right to buy)
100K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 16, 2026 | TENX TENAX THERAPEUTICS, INC. | Purchase(P) | 53,000 | $1.92 | $101,760 | Direct |
| Jan 9, 2026 | TENX TENAX THERAPEUTICS, INC. | Award(A) Stock Option (right to buy) | 30,000 | - | - | Direct |
| Jul 1, 2025 | TENX TENAX THERAPEUTICS, INC. | Award(A) Stock Option (right to buy) | 80,000 | - | - | Direct |
| Dec 10, 2024 | TENX TENAX THERAPEUTICS, INC. | Award(A) Stock Option (right to buy) | 100,000 | - | - | Direct |
1-4 of 4 transactions
About Doogan Declan
Doogan Declan (SEC CIK 0001704234) files insider reports with the SEC as Director of TENAX THERAPEUTICS, INC. (TENX).
Signal8 holds 4 ownership filings by Doogan Declan, all Form 4s, filed between Dec 12, 2024 and Sep 17, 2026. Those filings report 4 transactions, from Dec 10, 2024 to Sep 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Doogan Declan's filings is in CHAPEL HILL, NC.
Recent filings by Doogan Declan
Other insiders filing for TENAX THERAPEUTICS, INC. (TENX)
- ADAR1 Capital Management, LLC, 10% Owner
- Giordano Christopher Thomas, CEO
- STAAB THOMAS R II, Chief Financial Officer
- MCGAULEY THOMAS, Interim CFO
- Davidson Michael H., Director
- Rich Stuart, Chief Medical Officer